ArticleCancer medicine2024

Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study.

Irene Dogliotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.